COLO B Coloplast A/S Class B

Trading in Coloplast shares by board members, executives or associated persons

Trading in Coloplast shares by board members, executives or associated persons

Nasdaq Copenhagen

14 August 2019

Report on transactions of executives and related parties in Coloplast shares and

related securities

According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the

transactions of executives and their related parties in Coloplast shares and related securities.

The below transaction concerns the sale share.

1Details of the person discharging managerial responsibilities/person closely associated
a)NameJørgen Tang-Jensen
2Reason for the notification
a)Position/statusMember of the Board of Directors
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameColoplast A/S (CVR-no.: 69749917)
b)LEI529900NN7SOJ5QG82X67
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument B shares
Identification codeISIN: DK0060448595
b)Nature of the transactionSale of shares
c)Price(s) and volume(s)Price(s)Volumes(s)
817.208
817.0022
816.8060
816.4046
815.6090
815.6049
815.8045
815.40100
815.6058
815.6075
816.0037
816.0075
816.4075
816.6060
816.60100
816.8031
816.8075
817.0032
817.2022
817.2033
817.2013
817.2032
817.2075
817.40100
817.60151
815.0041
815.20200
815.8024
815.8060
815.20200
815.6058
816.2022
816.4058
815.2050
816.8040
815.6031
814.8075
815.0055
815.8075
d)Aggregated information 
-  Aggregated volume2,453 shares
-  Price816.08 DKK (volume weighted average)
e)Date of the transaction2019-08-14, 13:14
f)Place of the transactionNasdaq Copenhagen A/S (XCSE)

Attachment

EN
14/08/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Coloplast A/S Class B

 PRESS RELEASE

Coloplast A/S - Opdateret finanskalender 2025-26

Coloplast A/S - Opdateret finanskalender 2025-26 Venligst se vedlagte pdf.  Opdatering af datoer i finanskalenderen Coloplast har opdateret datoerne i selskabets finanskalender vedrørende offentliggørelsen af årsregnskabet for 2025/26 samt afholdelsen af den ordinære generalforsamling 2026. De opdaterede datoer er som følger: Årsregnskabsmeddelelse for 2025/26 og Årsrapport 2025/26: ændret fra 5. november 2026 til 3. november 2026Ordinær generalforsamling 2026: ændret fra 3. december 2026 til 1. december 2026 For yderligere information og kalenderinvitationer til kommende beg...

 PRESS RELEASE

Coloplast A/S - Updated Financial Calendar 2025-26

Coloplast A/S - Updated Financial Calendar 2025-26 Please see enclosed pdf. Update to Financial Calendar Dates Coloplast has updated the dates in its financial calendar for the publication of the FY Financial Statements 2025/26 and the Annual General Meeting 2026.  The updated dates are as follows: Financial Statements for the full year 2025/26 and Annual Report 2025/26: changed from November 5, 2026 to November 3, 2026Annual General Meeting 2026: changed from December 3, 2026 to December 1, 2026 For more information and calendar invitations for upcoming events, please visit:   Kind...

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen

ResearchPool Subscriptions

Get the most out of your insights

Get in touch